Human breast cancer cells (purple) are targeted by nanoparticles (green) developed by MIT professor Paula Hammond. The particles bind to receptors overexpressed by cancer cells.
Credit: Paula T. Hammond and Erik C. Dreaden
Modern medicine is largely based on treating patients with "small-molecule" drugs, which include pain relievers like aspirin and antibiotics such as penicillin.
From MIT News Office
View Full Article
No entries found